Cyclic HPMPC is safe and effective against systemic guinea pig cytomegalovirus infection in immune compromised animals

This publication has 23 references indexed in Scilit:

• Congenital cytomegalovirus infection and disease
  Seminars in Pediatric Infectious Diseases, 1999
• Clinical Pharmacokinetics of 1-[(( S )-2-Hydroxy-2-Oxo-1,4,2-Dioxaphosphorinan-5-yl)methyl]cytosine in Human Immunodeficiency Virus-Infected Patients
  Antimicrobial Agents and Chemotherapy, 1999
• Effect of Passive Antibody on Congenital Cytomegalovirus Infection in Guinea Pigs
  The Journal of Infectious Diseases, 1995
• 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl] cytosine, an intracellular prodrug for (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine with improved therapeutic index in vivo
  Antimicrobial Agents and Chemotherapy, 1994
• Evaluation of HPMPC therapy for primary and recurrent genital herpes in mice and guinea pigs
  Antiviral Research, 1993
• Comparative activity of selected antiviral compounds against clinical isolates of human cytomegalovirus
  European Journal of Clinical Microbiology & Infectious Diseases, 1991
• Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine in various models of herpes simplex virus infection in mice
  Antimicrobial Agents and Chemotherapy, 1991
• Cytomegalovirus infection in immunocompromised guinea pigs: A model for testing antiviral agents in vivo
  Antiviral Research, 1989
• Synthesis and antiviral activity of the nucleotide analog (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cystosine
  Journal of Medicinal Chemistry, 1989
• Effects of Cyclosporine on the Pathogenesis of Primary Cytomegalovirus Infection in the Guinea Pig
  Intervirology, 1985